Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Cutaneous Squamous Cell Carcinoma (CSCC)”
Approved 1
- CemiplimabREGENERON PHARMACEUTICALS, INC.Cutaneous Squamous Cell Carcinoma (CSCC)
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.